Eligibility NCT00778388 Pseudomonas Aeruginosa

written informed consent obtained prior to study entry

Ja

Nein

healthy adults aged between 18 and 65 years

Ja

Nein

no clinically relevant pathological findings in any of the investigations at the Screening visit. Minor deviations of laboratory values from the normal range may be accepted, if judged by the investigator to have no clinical relevance

Ja

Nein

In female subjects either childbearing potential terminated by surgery or a negative serum pregnancy test during screening and the willingness not to become pregnant during the entire study period by practicing reliable methods of contraception

Ja

Nein

History of autoimmune diseases and malignancies

Ja

Nein

Active or passive vaccination 4 weeks before and during the entire study protocol

Ja

Nein

Use of any other investigational or non-registered drug or vaccine in addition to the study vaccine during the study period or within 30 days preceding the first dose of study vaccine

Ja

Nein

History of severe hypersensitivity reactions and anaphylaxis

Ja

Nein

Known hypersensitivity or allergic reactions to one of the components of the vaccine

Ja

Nein

Clinically significant diseases as judged by the investigator

Ja

Nein

Immunodeficiency due to immunosuppressive therapy

Ja

Nein

A family history of congenital or hereditary immunodeficiency

Ja

Nein